The fallout from the demise of Roe v. Wade is forcing college administrators to weigh how reproductive health services offered on campus may conflict with state abortion bans and if their employees could face prosecution, Axios' Oriana Gonzalez writes.

Why it matters: The University of Idaho this week issued guidance that it could stop offering birth control, citing a section of the Idaho penal code dating back to the 1970s.

• The potential for other colleges to consider cutbacks is something "we are very concerned about," said Rachel Mack, director of marketing and communications for the American College Health Association.

The big picture: Abortion rights advocates say that state bans are designed to prevent people from not only getting an abortion, but from accessing other reproductive health care services.

• The language of the laws varies in matters like when life begins, creating a host of legal ambiguities, according to experts.
• "We're seeing a rush to hunker down and unfortunately cut people off from the information and care they need, likely at the behest of overly cautious legal counsel," said Andrea Miller, president of the National Institute for Reproductive Health, which advocates for access to abortion care.

Driving the news: The University of Idaho said that due to an "unclear and untested" 1972 anti-abortion law, the university will stop providing access to nearly all types of birth control.

• The memo sent to university employees cites language that a health provider who "publishes any notice or advertisement of any medicine or means ... for the prevention of conception" is guilty of a felony.

What they're saying: "While abortion can be discussed as a policy issue in the classroom, we highly recommend employees in charge of the classroom remain neutral or risk violating this law," said Jodi Walker, a spokesperson for the University of Idaho.

The other side: Abortion foes say that it is not their goal to restrict access to contraceptives.

• "No organization I'm aware of ... has called for such a policy change," said Kristi Hamrick, chief media and policy strategist for Students for Life for America, one of the largest anti-abortion organizations in the U.S.

Go deeper

The evacuations of thousands of patients from hurricane-stricken Florida health facilities this week served as an ominous warning to hospitals along the Atlantic and Gulf Coasts that researchers say could be swamped by surges from much weaker storms.

Driving the news: Rising sea levels and storms that are more violent and track farther north are posing new kinds of threats that health systems have to confront, according to a study published Thursday in GeoHealth.

What they're saying: "While the likelihood of a hurricane making landfall in the New York region or Boston is much less than places on the Gulf Coast, the consequences for access to hospital beds is, in fact, very high," Aaron Bernstein, a study co-author from Harvard T.H. Chan School of Public Health, told Axios.

By the numbers: Researchers identified 682 acute care hospitals in 78 metropolitan statistical areas located within 10 miles of the Atlantic and Gulf Coasts.

• The study found almost a third of those metro areas have half or more of their hospitals at risk of flooding from a Category 2 hurricane.
• A sea level rise of .82 meters, which is estimated to occur this century, would increase the odds of hospitals flooding by 22%, they said.

Read the rest

Requiring that a threshold for racial and ethnic diversity in medical trials be met as a condition for researchers to publish in major journals could be key to improving research into cancer and other diseases, writes Marina E. Franco of Noticias Telemundo for Axios.

Why it matters: Clinical trials are supposed to represent a cross section of who will be impacted by a medical product because people of different races, ethnicities, ages and genders may react differently, per the FDA.

• But too often, non-white groups are underrepresented in science.

Details: Two oncologists developed a strategy they call DRIVE, published in Blood Advances, that called for trials to receive points based on representation.

• Researchers would need a score of three before they can present their work at major medical conferences or be published in major journals.

The bottom line: While the FDA published recommendations in April for companies to increase trial diversity, they're nonbinding. The researchers argue there need to be mechanisms that require a follow-through.

"For a lot of science, [the cost of sequencing] is like the price of gas."

Meet Manzur, a miracle pup who was set for euthanasia three times due to overcrowding at an Atlanta shelter before he found his humans.

• "He has been the most perfect dog, ever, for our family," writes his human Angelena Ledford. "He now works as a therapy dog and travels all over the country with us."
• Manzur is also a "pupfluencer" on social media. You can find him under his handle @ManzurLB.